戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  for human diphtheria, its use often induces serum sickness.
2        None of the patients had evidence for serum sickness.
3  during mobilisation, 9 patients experienced serum sickness, 6 patients required intensive care unit
4             Renal transplant recipients with serum sickness after polyclonal antibody therapy may ben
5 five renal transplant patients who developed serum sickness after polyclonal antibody treatment with
6                               The studies in serum sickness and anti-GBM nephritis led to an understa
7 ted an adverse event, including rash, fever, serum sickness, and anaphylaxis.
8 ugh, asthenia, sensory neuropathy, anorexia, serum sickness, and hypertensive encephalopathy.
9 gic vasculitis, leukocytoclastic vasculitis, serum sickness, and others, which are often used interch
10 es, anaphylactic or anaphylactoid reactions, serum sickness, and thrombocytopenia.
11 nimal sera have many disadvantages including serum sickness, batch-to-batch variation in quality and
12 ute allergic reaction by Brown criteria, and serum sickness by formal criteria.
13 an induce immune complex diseases, including serum sickness disease (SSD).
14  strongly immunogenic and rabbit ATG induces serum sickness disease in almost all patients without ad
15 eterologous apoferritin to study the chronic serum sickness GN model.
16 hrombocytopenia developed in 14 patients and serum sickness in 6 others.
17 e ("tumor flare") (in 11%), anemia (in 11%), serum sickness (in 8%), and fatigue (in 8%).
18                          Toxicities included serum sickness (in all patients), transient neutropenia
19 lement, which led to spontaneous and chronic serum sickness-induced proliferative glomerulonephritis.
20                                              Serum sickness is an immune-complex mediated illness tha
21                                              Serum sickness-like disease occurred in 19 of 500 patien
22 der untoward autoimmune reactions, including serum sickness-like disease, drug-induced lupus, and aut
23  of infrequent but serious events, including serum sickness-like reaction, opportunistic infection an
24 -inflammatory drug-associated angioedema and serum sickness-like reactions, are more frequent among y
25 ephritis, which was accelerated in a chronic serum sickness model by active immunization with heterol
26                                              Serum sickness occurred in 27 (82%) participants in the
27         No active tuberculosis, anaphylaxis, serum sickness, or clinically important hepatic disorder
28                                              Serum sickness presents with significant morbidity but i
29  discontinuation of treatment, 1 developed a serum sickness reaction after completion of therapy, and
30               To decrease the possibility of serum sickness, the equine antisera was digested with pe
31                                      Chronic serum sickness was induced by active immunization with a
32 oup examining the models of acute or chronic serum sickness were major for our understanding of renal
33 group had both cytokine release syndrome and serum sickness, which was associated with a transient ri